Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Phase III, Randomized Study of Pneumococcal Conjugate Vaccination in HIV, in Comparison to Polysaccharide Vaccine Boosting in Previously Vaccinated Patients

NCT00622843 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT00622843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00622843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Phase III, Randomized Study of Pneumococcal Conjugate Vaccination in HIV, in Comparison to Polysaccharide Vaccine Boosting in Previously Vaccinated Patients
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
July 31, 2013
Enrollment
275 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, streptococcus pneumoniae